Sunil Healthcare Ltd. · BSE:SUNLOC
Sunil Healthcare — Q3 FY2018 Earnings Presentation
30 slides from Sunil Healthcare's earnings presentation, Feb 16, 2018
Slide 1: Cover letter to Bombay Stock Exchange
@suntoc SHL/SEC/2018 February 16, 2018 Bombay Stock Exchange Limited Listing Department, Ist Floor, New Trading Ring, Rotunda Building, Phiroze JeeJeeBhoy Towers, Dalal Street, Fort Mumbai — 400 001. Company Code: 537253 Sub.: Investor Presentation for 3 quarter/ nine months ended December 31 ,2017.
Slide 2: Investor Presentation – February 2018
Sunil Healthcare Ltd. Investor Presentation – February 2018
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the Presentation ), which have been prepared by Sunil Healthcare Limited (the Co pa y ), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securi
Slide 4: 9MFY18 Performance Highlights
9MFY18 Performance Highlights Rs. Mn. Net Revenue* EBITDA Profit Before Tax 736.6 130.3 67.8 669.9 113.5 44.4 9MFY17 9MFY18 9MFY17 9MFY18 9MFY17 9MFY18 Profit After Tax Cash PAT Cash PAT Margin % 45.4 77.9 10.6 9.1 61.2 26.5 9MFY17 9MFY18 9MFY17 9MFY18 9MFY17 9MFY18 3 * Net Revenue = Gross Revenue –
Slide 5: Q3/9MFY18 – Income Statement as per IndAS
Q3/9MFY18 – Income Statement as per IndAS Rs. Million Q3FY18 Q3FY17 YoY % 9MFY18 9MFY17 YoY % Net Revenue* 229.2 281.7 -18.6% 669.9 736.6 -9.1% Capsule 198.3 205.3 596.6 621.8 Marketing of Food Product 30.9 76.4 73.3 114.8 Raw Material 97.6 155.2 281.0 361.8 Employee Cost 30.6 25.2 88.7 75.2 Other E
Slide 6: Balance Sheet as per IndAS
Balance Sheet as per IndAS Rs. Million Sept -2017 Rs. Million Sept -2017 Assets Equity & Liabilities Non current Assets 633.6 Equity 454.7 Fixed Assets Property Plant & Equipment 572.1 Share Capital 102.5 Capital WIP 34.8 Other Equity 352.2 Other Intangible Assets 3.1 Non Current Liabilities 220.9 F
Slide 7: Balance Sheet as per I-GAAP
Balance Sheet as per I-GAAP Rs. Million Mar -2017 Sept-2016 Mar-2016 Shareholders Fund 371.6 343.0 310.6 Share Capital 102.5 102.5 102.5 Reserves & Surplus 269.1 240.5 208.1 Total Non Current Liabilities 181.7 188.9 131.9 Long Term Borrowings 128.2 142.4 91.6 Deferred tax liabilities (net) 40.5 33.5
Slide 8: Our Story
@suntoc o> a= ~v Uur Story =
Slide 9: Company Snapshot
Company Snapshot 2nd Largest producer of Empty Hard Gelatin Capsules (EHGC) in India Pioneer Download of Double this awesome Lock and Triple Lock diagram. Capsules in India 02 Global Presence with ~40% Exports Revenue ‘e og ized as a “TA‘ EXPO‘T HOU“E y GoI Preferred Vendor for Large Pharmaceutical
Slide 10: Our Journey
Our Journey 2013 – Entered Foods Business with Sunloc foods. 2010-15 State of the Art HVAC System Renewed interest in the Fo usi g o Quality business with an aim to 2003 Assurance and become top 3 Auto atio manufactures of capsules in India Focus on increasing export 1990’s revenues Slow
Slide 11: Management Team
Management Team Mr. Anil Khaitan - Promoter and Chairman cum Managing Director Mr. Anil Khaitan is an MBA from IMD, Geneva, 1981 Over 37 years of wide experience in Industries ranging from Steel, Copper, Paper, Jute, Wires, Foods, Pharmaceutical and Retail Chairman - CSR PANEL CII DELHI and Pr
Slide 12: Core Competencies to lead GROWTH
Core Competencies to lead GROWTH 01 02 03 Huge Industry Potential Wide Product Range Unique Product Offering 04 State of Art 05 06 Quality Focus Regulatory Certifications Manufacturing Facility 07 08 09 Global Presence Marque Clientele Brownfield Expansion 10 12 Economies of Scale 11
Slide 13: Huge Industry Potential
01 Huge Industry Potential Pharma exports were pegged at US$ 15 bn with a CAGR of 15% over the last 5 years Indian Pharma market is expected to grow at a CAGR of 13.6% - US$ 50 bn in 2020 In India, manufacturing cost is competitive as compared to the Western countries. Cost of innovation is 5t
Slide 14: Wide Product Range
02 Wide Product Range We offer all range of capsules and TSE Free Preservative Free Stick Free have abilities to customise products Capsules can be transparent, coloured (same or different), partially opaque or completely SLS Free Liquid Filled Pearl Finished opaque Sizes Available - 00,OSEL,
Slide 15: Unique Product Offering
03 Unique Product Offering Product Product Range caters to Pharma & Food Supplement Industry Customize Strengths and Appearance can be modified as per client requirement Suitability Suitable for filling on high speed machines with capacities upto 3,00,000 caps/hr Printing Linear, Circular & 360 degr
Slide 16: State of Art Manufacturing Facility
04 State of Art Manufacturing Facility WHO-GMP certified facility Zero Dis harge with fully auto ated ETP Latest Generation PLC controlled high- speed automatic machines State of Art HVAC system from Kruger, Trane, Carrier, Zeco Experienced Six Sigma Qualified team 22 automatic productio
Slide 17: Quality Focus
05 Quality Focus Internationally Accepted Measures TPAM, 5S, Jishu Hozen across Stringent Quality Compliance Measures Adopted for production lines zero defe t apsules Six Sigma, for process control and Process R&D: Industry Leader for efficient utilization product control of primary raw mate
Slide 18: Regulatory Certifications
06 Regulatory Certifications ISO-22000:2005 WHO-GMP ISO-14001:2004 NSF /9001:2008 TGA US FDA-DMF TYPE-IV Health Canada GDP AUSTRALIA Halal-JAKIM GLP OHSAS 18001:2007 Malaysia 17
Slide 19: Certifications – Raw Material (Gelatin)
Certifications – Raw Material (Gelatin) HALAL KOSHER Gluten EDQM Free Aflatoxin Veterinary BSE/TSE FREE 18
Slide 20: Global Presence
07 Global Presence Presence in Over 30 Countries across the Globe Recognized Star Export House 19
Slide 21: Marquee Clientele
08 Marquee Clientele @suntoc Wyeth @)..... CRD Abbott © CADILA APromise for Life Expressions for healthy fife — SS”
Slide 22: Brownfield Capacity Expansion Completed
09 Brownfield Capacity Expansion Completed Bn Capsules 13.0 Capacity Expansion expected to be completed 2.0 by Q4FY18 taking the 1.0 total available capacity to 13bn capsules p.a. 2.3 7.7 The incremental capacity shall be commissioned in Q4FY18 Capacity Expansion – to drive increased revenue s
Slide 23: Economies of Scale
10 Economies of Scale 11 billion p.a Capsules Capacity at a Single Location at Alwar, Rajasthan Infrastructure Human Resource 01 Common Infrastructure and Utilities Shared Commercial & Technical Resources 02 Control 03 Better Control and Smooth Running of the Plant Procurement & Dispatch Better Nego
Slide 24: Sunloc Foods - (A division of Sunil Healthcare)
Sunloc Foods - (A division of Sunil Healthcare) Division started in 2013 Engaged in marketing of Nuts, mainly Cashews Building Capabilities in Supply Chain 18% Revenue Contribution in FY17 Awarded Top Most Exporter under Cashew nut & allied products from The Cashew Export Promotion Council
Slide 25: Building Strength
Building Strength Brownfield Expansion Completed Driving growth with profitability HPMC product Launched Supplied and Delivered to new overseas geographies Credit Rating Moves Up Credit Rating moved a notch up, reaffirming our growing stability Healthcare Leadership Award Wo The Best Use of “ix Sigm
Slide 26: Business Excellence Awards
Business Excellence Awards Healthcare Leadership Award – Six Sigma Wo The Best Use of Six Sigma In Healthcare Award at the Healthcare Leadership Awards, hosted by ABP News No e er 5 Business Excellence Award 2015 Received the prestigious Business Excellence Award 2015 for Excellence in Manufacturing
Slide 27: Business Momentum
Business Momentum In Rs. 1,036 Mn 177 Mn 61 Mn *Total Income - FY17 EBITDA – FY17 PAT - FY17 21.8%*Total Income 21.6% 44.5% EBITDA PAT 5 Years CAGR 5 Years CAGR 5 Years CAGR 26 *Total Income = Net Revenue + Other Income – Excise Duty Financials are as per I-GAAP
Slide 28: Annual Income Statement as per I-GAAP
Annual Income Statement as per I-GAAP Rs. Million FY17 FY16 FY15 FY14 FY13 Total Income* 1,036 829 734 622 470 Raw Material 517 353 319 214 141 Employee Cost 109 94 86 71 62 Other Expenses 233 225 204 220 186 EBITDA 177 157 125 117 81 EBITDA Margin 17.1% 18.9% 17.0% 18.8% 17.2% Interest 42 38 23 25
Slide 29: Balance Sheet as per I-GAAP
Balance Sheet as per I-GAAP Rs. Million FY17 FY16 FY15 FY14 FY13 Shareholders Fund 372 311 258 231 198 Share Capital 102 102 102 102 102 Reserves & Surplus 270 208 156 129 96 Total Non Current Liabilities 181 132 82 66 73 Long Term Borrowings 128 92 57 38 43 Other Long Term Liabilities 53 40 25 28 3
Slide 30: For further information, please contact
For further information, please contact: Company : Investor Relations Advisors : Sunil Healthcare Ltd. Strategic Growth Advisors Pvt. Ltd. CIN - L24302DL1973PLC189662 CIN - U74140MH2010PTC204285 Mr. Pawan Rathi, Chief Financial Mr. Shogun Jain / Mr. Pratik R. Shah Officer shogun.jain@sgapl.net / pra